Watson Sheds Rugby OTC Drug Line In $117M Deal
Watson Pharmaceuticals Inc. has agreed to let generic drugmaker The Harvard Drug Group LLC snap up its Rugby product line and trademarks in a $117 million deal, the companies announced Monday....To view the full article, register now.
Already a subscriber? Click here to view full article